Site Search
Search Results
Survivor Views of Pharmacogenomic Testing
... at all levels of government. Fielded June 26-July 19, 2023, our latest survey explores awareness of and attitudes toward pharmacogenomic (PGx) testing, a form of genetic testing to better understand a patient’s risk for drug reactions. The web-based survey was conducted among 1,155n cancer patients and survivors ... same drug. These differences may impact the effectiveness of a drug or the side effects a person may experience. (Note: this is different from biomarker testing of a tumor to help determine which drug may be used) Four-in-Ten Aware of PGx Testing Based on the definition above, 42% of ...
Survivor Views: One in Ten Impacted by Recent Drug Shortages
... our latest survey explores the impact of recent drug shortages on cancer patients and survivors, as well as experiences with telehealth and biomarker testing. The web-based survey was conducted among 1,222n cancer patients and survivors nationwide who have been diagnosed with or treated for ... substitute medications (68%), treatment delays (45%), and difficulties related to insurance coverage, such as coverage for an alternate therapy. Biomarker Testing Over three-quarters (77%) of survey respondents who have had biomarker testing agree that the results gave their provider ...